LDOS vs REPL
Leidos Holdings Inc (LDOS) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
REPL does not have a complete income-statement cache yet.
LDOS currently screens at market cap $20.04B and trailing P/E 15.7. REPL currently screens at market cap $825.7M.
Not investment advice. Open the LDOS and REPL stock pages for the full models.
Not investment advice.